Yanju Li
Guiyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Efficacy and safety of combination versus single-agent immunotherapy for BCG-unresponsive non-muscle-invasive bladder cancer.
Journal: Frontiers in immunology
Published: May 31, 2026
miR-2110 orchestrates ERK-ELK1 transcriptional repression to induce cell-cycle arrest and enhance cytarabine sensitivity in acute myeloid leukemia.
Journal: Frontiers in oncology
Published: March 18, 2026
Asparagus Saponin Officinalisnin-II Alleviates Fluoride-Induced Neurotoxicity Via Activation of the SIRT1/BDNF Signaling Pathway.
Journal: Biological trace element research
Published: January 25, 2026
Sodium fluoride induces cardiotoxicity via TGF-β-mediated suppression of the Wnt/β-catenin signaling pathway.
Journal: Toxicology and applied pharmacology
Published: January 09, 2026
Fluoride Damages the Ovary by Inhibiting LKB1-AMPK Signaling to Promote Mitochondrial Injury-Induced Inflammation and Oxidative Stress.
Journal: Biological trace element research
Published: November 23, 2025
Clinical efficacy study on the combined treatment of cancer-related depression with traditional Chinese acupuncture-related therapies and drugs.
Journal: Frontiers in psychiatry
Published: October 01, 2025
Disruption of the SIRT1/PI3K/AKT Signaling Axis Mediates Fluoride-Induced Cardiotoxicity: Evidence from in Vitro and Zebrafish Models.
Journal: Biological trace element research
Published: July 30, 2025
The ALDH2-PKC delta-SHMT2 axis regulates cellular metabolic plasticity to promote leukemia stem cells self-renewal and evasion of chemotherapy in AML.
Journal: Cancer letters
Published: May 23, 2025
Acute myeloid leukemia cells induce senescence and adipogenic differentiation of mesenchymal stem cells in a tumor-supportive microenvironment at the same time.
Journal: Cellular signalling
Published: May 20, 2025
SLC44A1 promotes AML progression and chemoresistance by regulating the Notch signaling pathway.
Journal: Neoplasma
Published: May 18, 2025
Efficacy and safety of CD19 combined with CD22 or CD20 chimeric antigen receptor T-cell therapy for hematological malignancies.
Journal: Frontiers in immunology
Published: February 15, 2025
Last Updated: 09/26/2026